Sign in
Taking people in United StatesNo phase

Imaging the Lungs of People With Cystic Fibrosis or Bronchiectasis

Studies lung imaging in people with cystic fibrosis or non-CF bronchiectasis, using xenon gas.

Key facts

Who runs it
Children's Hospital Medical Center, Cincinnati
Where
Cincinnati, United StatesSee the site
Trial code
Registry title
Regional Phenotyping of CF and Non-CF Bronchiectasis
Status
Recruiting
People taking part
100 people, planned
Started
8 Feb 2021
Expected to end
31 Dec 2028
Type of study
Observational, 2 groups
Treatments tested
  • Xenon
Record updated
7 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and adults with cystic fibrosis, and also healthy people with no known heart or lung disease. All must be at least 5 years old.

Age
From 5 years to 100 years
Sex
All sexes can join
Disease stage
Cystic fibrosis confirmed by sweat chloride above 60 mMol/l. No stage or severity is stated.
Biomarker or test result
Two disease-causing CFTR mutations, or signs of the disease in other organs.

Main reasons for not taking part

  • Cannot have an MRI scan (for example metal implants that are not MRI-compatible, or claustrophobia)
  • Pregnancy
  • Breastfeeding

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • CF Patients: Diagnosis of CF based on sweat chloride >60 mMol/l
  • Presence of two disease causing CFTR mutations, or end organ manifestations of disease
  • Age minimum 5 years
  • Care provided by the CCHMC CF Care Center or other regional CF Care Centers if required to achieve recruitment goals
  • Subjects 5 years of age and older with no known history of cardiopulmonary disease

Who cannot take part

  • Patients meeting standard MRI exclusions criteria (non-MRI-compatible metal implants, claustrophobia, etc.)
  • Patients meeting standard MRI exclusions criteria (non-MRI-compatible metal implants, claustrophobia, etc.)
  • Pregnancy or lactation
  • Pregnancy or lactation

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 5 and 100 years old?

Where in United States

  • Penny NewCincinnati, United StatesContact: Penny A New, BBATaking people

About the trial

What the trial wants to find out

The Investigators propose to study pediatric subjects who are diagnosed with cystic fibrosis (CF) and patients with non-CF bronchiectasis, with the goal of developing markers of CF lung disease severity, progression, and therapy response. The Investigator's central hypothesis is that image-based markers can forecast pathophysiology prior to spirometric changes.

The 2 groups in the trial

  • CF and Non-CF Bronchiectasis

    In the first arm (Aims 1 \& 2) Up to 50 subjects will be recruited-approximately 25 with normal FEV1 (\>85% predicted) and 25 with mild to moderate disease. All subjects will be asked to undergo longitudinal (i.e., approximately annually) 129Xe and UTE MRI, spirometry, and lung clearance index (LCI) measurement.

    Treatment: Xenon

  • Healthy Subjects

    Up to 50 age and sex matched control subjects (i.e., subjects with no known cardiopulmonary disorders) may also be recruited to provide a reference data set from healthy subjects for comparison.

    Treatment: Xenon

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Regional Phenotyping of Cystic Fibrosis Lung Disease and Non-CF Bronchiectasis
Plain-language title
Imaging the Lungs of People With Cystic Fibrosis or BronchiectasisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT04793867, who can take part
Record updated
7 October 2026